1. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society 2014;64(21):e1-e76.
2. Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M, et al. Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter. JACC. 2015;8(4):772–6.
3. Anand V, Vakil K, Tholakanahalli V, Li J-M, McFalls E, Adabag S. Discontinuation of dofetilide from QT prolongation and ventricular tachycardia in the real world. JACEP. 2016;2(7):777–81.
4. Cho JH, Youn SJ, Moore JC, Kyriakakis R, Vekstein C, Militello M, et al. Safety of oral dofetilide reloading for treatment of atrial arrhythmias. CIRCEP. 2017;10(10).
5. Turagam MK, Afzal MR, Reddy M, Pillarisetti J, Lavu M, Atkins D, et al. Practice variation in the re-initiation of dofetilide: an observational study. Int J Cardiol. 2017;236:221–5.